Unveiling a Visionary Leader: Dr A Burton Tripathi Assumes CEO Role at Beyeonics

Dr A Burton Tripathi

Beyeonics Vision Ltd., a pioneering MedTech company in the field of digital surgical platforms for imaging during ophthalmic procedures, announces the appointment of Burton Tripathi, PhD, as its new Chief Executive Officer. This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.

Experience

Dr. Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.

New Role Responsibilities

In his new role as CEO of Beyeonics Vision, Dr. Tripathi will lead the company’s strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.

Yoram Shmuely, Chairman of the Beyeonics Vision Board

“We believe Mr. Tripathi’s leadership will continue to drive innovation and push forward Beyeonics Vision into the market. His appointment reflects our dedication to delivering cutting-edge solutions that enhance patient care. We also extend our gratitude to Mr. Ron Schnieder for his leadership in recent years, and we look forward to his continued contributions as a board member.”

Dr. Tripathi

“I am honored to be appointed as CEO of Beyeonics Vision. The company has an impressive portfolio of advanced technology and a talented team of employees. Together we are committed to building on the company’s groundbreaking innovation and advancing our mission to transform patient care in Ophthalmology”, Dr. Tripathi shared.

A leading figure in the transformation of surgical visualization from analog to digital, Dr. Tripathi, author of over 30 patents, has been instrumental in the adoption of digital imaging technology across all types of microsurgery. Dr. Tripathi has a Doctorate from the California Institute of Technology and a Bachelor’s from Cornell University both in Mechanical Engineering. He began his career at McKinsey & Company, followed by advancing leadership roles with Intuitive Surgical, Allergan, and Alcon.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.